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Background: Physical activity is prescribed as a component of primary management for Polycystic Ovary Syndrome
(PCOS). This study investigates the association between physical activity and mental health as well as the exercise
barriers, motivators and support providers for younger women with and without PCOS to assist in physical activity
uptake and prescription for these women.
Methods: Women aged 18-50 years with (n = 153) and without PCOS (n = 64) completed a questionnaire at one
time point. The questionnaire included the Hospital Anxiety and Depression Scale and a survey regarding levels of
physical activity, physical activity barriers, motivators and supports. A MANCOVA assessed associations between
physical activity, PCOS and mental health (specifically depression and anxiety). Descriptive and Chi square goodness
of fit statistics assessed the differences in perceived barriers, motivators and support providers amongst women
with and without PCOS.
Results: Women with PCOS displayed higher severity of depression (F(1,210) = 8.32, p = 0.004) and anxiety (F(1,210)=
17.37, p < 0.001) symptoms compared to controls. Overall, for physically active women, depression was significantly less
severe than in their inactive counterparts (F(2,210) = 13.62, p < 0.001). There were no differences in anxiety by physical
activity status and no interaction effects between PCOS and activity status for depression or anxiety. Women with PCOS
were more likely to report a lack of confidence about maintaining physical activity (Χ2 = 3.65; p = 0.046), fear of injury
(Χ2 = 4.08; p = 0.043) and physical limitations (Χ2 = 11.92; p = 0.001) as barriers to physical activity and were more likely
to be motivated to be active to control a medical condition (Χ2 = 7.48; p = 0.006). Women with PCOS identified more
sources of support compared to women without PCOS.
Conclusions: Physical activity is associated with lower depression in women with PCOS and differences exist in the
self-reported physical activity barriers, motivators and support providers, compared to controls. Being more active may
offer mental health benefits in managing PCOS. Prescribing physical activity to women with PCOS should be
individualized and consider both common and PCOS-specific barriers and motivators for successful engagement.
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Polycystic ovary syndrome (PCOS) is one of the most
common and complex endocrine disorders and the lead-
ing cause of anovulatory infertility in reproductive aged
women. PCOS affects between 12-21% of reproductive
aged women, depending on diagnostic criteria, with many* Correspondence: nigel.stepto@vu.edu.au
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unless otherwise stated.cases being undiagnosed [1,2]. PCOS has reproductive,
psychological and cardio-metabolic features [3-7] and is
associated with many long term adverse health problems
including increased risk of obesity [4,8,9], type 2 diabetes
and metabolic impairments [10-13], and cardiovascular
risk factors [14,15]. We and others have shown that di-
minished mental health is related to PCOS, including de-
pression, anxiety and lower quality of life [16-18]. These
mental health differences are noted across the lifespan, in-
cluding adolescents, and across the different PCOS pheno-
types [19,20].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and are associated with reduction in quality of life and
increases in depressive symptoms [21-24]. In PCOS,
symptoms and co-morbidities increase the risk of adverse
mental health consequences. Coping with the condition it-
self, fears regarding infertility, loss of femininity and sexu-
ality, body image concerns and lower self-worth may all
contribute to poorer mental health outcomes [7,18,25].
Mental health is especially relevant in PCOS management
as it is vital to self-efficacy around a healthy lifestyle (in-
cluding physical activity). Therefore optimisation of phys-
ical activity as a treatment for PCOS, as recommended by
the first Evidence based Guideline for the Assessment and
Management of PCOS [26], should consider the mental
health status of women with PCOS and the interactions
with physical activity.
Lifestyle management, including healthy diet and phys-
ical activity, is currently advised as the first line manage-
ment strategy for PCOS [26]. Physical activity is an
effective therapeutic option for the reproductive [27,28]
and metabolic features [29] of PCOS. The specific inter-
action between physical activity and mental health has not
been explored in depth in PCOS, however, preliminary
data including a recent clinic-based study of women with
PCOS found physically inactive women had higher de-
pression scores than physically active women, and there
was an association between lower physical activity and
mild depression [30]. Reductions in depression and eleva-
tions in quality of life have been observed in combined
physical activity and dietary interventions in PCOS [31]
and specific physical activity interventions have been
found to be effective in reducing mild-moderate depres-
sion [32,33] and anxiety [34] in the general population.
Yet engagement and sustainability in physical activity in
women with PCOS is particularly problematic. Despite the
positive physical effects of exercise [35], the inherent
symptoms and co-morbidities associated with PCOS may
present barriers to engagement in physical activity and
may impact on typically positive psychological responses
to being physically active. Thus, research investigating the
relationship between physical activity and mental health
for women with PCOS and exploration of the enablers
and the barriers to activity is important for appropriate
prescription of physical activity Additionally, as attrition in
PCOS physical activity research interventions is typically
high (30-40%) [29,31,35] and physical activity maintenance
in PCOS is generally inadequate, understanding the bar-
riers and motivators of physical activity for women with
PCOS is required to promote engagement and sustainabil-
ity. Little is known about the barriers and motivators of
physical activity that specifically effect women with PCOS,
and being the first study to explore physical activity bar-
riers and motivators among this population of women, the
study was considered hypothesis generating.We hypothesised that physical activity would be associ-
ated with better mental health, specifically a lower severity
of both anxiety and depression, for all women. Further-
more, the study aimed to describe the common barriers
and motivators to physical activity for women with PCOS
compared to a control sample of women. We expected
some barriers and motivators to differ between women
with and without PCOS and that they may vary according
to age [36].Methods
Participants
This sub-study focused on physical activity as part of a
broader study investigating health-related behaviour in
women with and without PCOS. Study recruitment has
been described in detail previously [18]. This was a
cross-sectional, observational study utilising devised
and validated questionnaires. Southern Health Human
Research Ethics Committee C (Project No. 07070C) ap-
proved this study and the procedures involved. All
women provided informed consent to participate in the
study. Women responded to recruitment advertise-
ments across a range of community health settings in-
cluding medical clinics, print media, online women’s
health sites and an online PCOS support group. Women
needed to be living in Australia, aged between 18
and 70 years and able to read and write in English.
Women with and without PCOS were recruited in this
manner. PCOS status was then determined based on
self-reported previous medical diagnosis (Rotterdam
criteria) [37] and the presence of at least two of the fol-
lowing (self-reported during phone screening); polycys-
tic ovaries on ultrasound, high androgen levels/clinical
hyperandrogenism and menstrual irregularity. Only the
women aged 18- 50 years were included for analysis to
reduce any potential confounding effects of menopause
(average age of onset is 51 years) which is associated
with mental health outcomes [38]. Pregnant women,
women living overseas, women with a psychiatric illness
(other than anxiety or depression) or an incomplete
PCOS diagnosis were excluded from the research. Par-
ticipants completed the survey in either online or writ-
ten format according to their preference.Measures
Body mass index
BMI was calculated based on self-reported weight and
height (weight/height(m)2). This population (adult women)
is known to typically underestimate their weight and over-
estimate their height (therefore reducing estimated BMI)
[39], however, any adjustments required would be common
to both groups.
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A simple, devised measure based on the trans-theoretical
model TTM; [40] was used to assess participants’ physical
activity levels. As this was part of a large study exploring
many aspects of health related behaviour this tool was
used rather than longer physical activity tools or pedome-
ters to reduce the burden on participants while gaining a
general indication of the individual’s habitual physical ac-
tivity. A definition of physical activity based on the Na-
tional Physical Activity Guidelines for Australians was
provided to participants. These guidelines define physical
activity in a very similar way to other organisations includ-
ing the World Health Organisation [41]. Participants se-
lected a statement of agreement with each phrase typically
used to describe the pre-contemplation (I currently do not
exercise and I don’t intend to start exercising any time
soon), contemplation (I currently do not do exercise how-
ever I am thinking about exercising in the next few
months), preparation (I occasionally exercise now, but not
on a regular basis), action (I currently exercise on a regular
basis and have done so for the past 6 months) and main-
tenance (I currently exercise on a regular basis and have
done so for more than 6 months) stages of the TTM. Re-
sponses ranged from 1 (Definitely agree) to 4 (Definitely
disagree). Women were classified as physically active if
they reported agreement (definite or somewhat agree-
ment) for the active or maintenance stages of the TTM
questionnaire.
Mental health measures
The Hospital Anxiety and Depression Scale HADS; [42] is
a state measure of anxiety and depression, used to detect
clinical cases and the severity of both conditions. The scale
consists of 14 items, 7 measuring depression, 7 measuring
anxiety. The measure displays high internal consistency for
both anxiety (α = .93) and depression (α = .90) [43]. The
scores can be used as a continuous variable, with higher
scores (out of a possible 21) indicating greater anxiety or
depression. A score of 8 or greater indicates possible pres-
ence of anxiety and/or depression.
Physical activity barriers and motivators questionnaire
Women were presented with two lists comprised of com-
monly reported physical activity barriers and motivators.
Participants were asked to nominate which of the barriers
were ‘main factors that prevent/stop’ them from engaging
in physical activity. The items included 12 barriers com-
monly associated with physical activity. Participants could
also nominate barriers in the ‘other’ category. This option
resulted in ‘no enjoyment’ being analysed as a 13th barrier.
For the motivators, participants were asked to identify the
items which they considered to be ‘the main advantages of
engaging in physical activity’. Items included 13 motiva-
tors frequently cited as reasons for physical activity andagain, participants could nominate other items which re-
sulted in ‘enjoyment/fun’ and ‘time to think’ being in-
cluded for analysis. The barriers and motivators were
selected from international physical activity literature with
specific local barriers and motivators selected from the
Main Barriers and Motivators Report by the Australian
Bureau of Statistics [44].
Physical activity supports
From a list of 9, women were asked to select individuals
or groups that ‘are most important to you when you think
about engaging in physical activity’. These supports were
chosen from previous literature and current Australian
physical activity reports concerning physical activity facili-
tation [44]. Women could select as many as relevant and
nominate in an ‘other’ category, resulting in ‘myself ’, ‘no
one’, ‘exercise acquaintances or team mates’ and ‘pets’ be-
ing included for analysis.Data analysis
Statistical analysis
Analysis was performed using SPSS version 19. The out-
come variables, anxiety and depression, were determined to
be normally distributed. A two-way between groups
MANCOVA was conducted to determine significant
mean differences in mental health (anxiety and depres-
sion) amongst the sample according to physical activity
(active vs. inactive) and PCOS (PCOS vs. non PCOS).
Age and BMI were used as covariates given the signifi-
cant role each variable has been shown to have on men-
tal health [38,45]. Bonferroni adjustments were used to
assess statistical significance for single dependent vari-
ables (two-sided p-value of 0.025). Independent t-tests
were used to assess individual differences according to
PCOS and physical activity. Numbers of physically ac-
tive and inactive women with and without PCOS were
assessed using a chi-square goodness of fit analysis with
statistical significance assumed with a two-sided p value
of 0.05. Barriers, motivators and physical activity sup-
ports were assessed using descriptive statistics, calculat-
ing percentages of each group reporting the barrier as a
main factor that prevents physical activity which were
compared using chi-square goodness of fit analyses. Re-
sults were assessed across the entire sample and also
considering age groups (18-30 years, 31-40 years and
41-50 years to represent typical life stages) to determine
whether barriers, motivators and supports differed. The
barriers, motivators and supports were also compared
between groups in only healthy weight women (BMI =
18-25). The number of barriers, motivators and sup-
ports identified by each group was compared using an
independent samples t-test. Statistical significance was
assumed with a two-sided p-value of 0.05.
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Participation and demographics
After considering the inclusion criteria, 240 women
were included for analysis. Twenty three (9.6%) women
were excluded from further analysis due to inconsistent
responses to the TTM questions for physical activity.
Women who indicated agreement with both inactive
and active stages (or disagreement with all stages) were
removed from analysis as this response pattern indicates
a misunderstanding of the question, or erratic physical
activity behaviour. The remaining sample (N = 217)
were included in the analysis and had a mean age of
31.84 years (SD = 7.74) and were on average overweight
with a mean body mass index (BMI) of 29.23 (SD =
7.90). Women with PCOS accounted for 70.5% of the
sample (n = 153) and had a higher mean BMI than the
control group (Table 1). Of the 40 women born overseas
17 (43%) were born in Europe (United Kingdom of
Great Britain, Italy, Portugal, Netherlands), 11 (28%)
were born in Asia (Hong Kong, India, Sri Lanka,
Indonesia, Laos, Malaysia, Singapore), 5 (12%) were
born in Africa (Kenya, Zimbabwe, South Africa), 5
(12%) were born in Oceania (New Zealand, Papua New
Guinea) and 2 (5%) were born in America (Chile,
United States of America).Table 1 Descriptive statistics according to PCOS status
PCOS
n = 153
Control
n = 64
P-value
Age (SD) 31.99 (6.80) 31.50 (9.69) 0.674
BMI (kg/m2) 31.32 (7.71) 24.15 (5.77) <0.001
Diagnosed infertility (%) 37 0 -
Highest level of education 0.897
No formal qualification (%) 13 17
Formal qualification 87 83
Born in Australia (%) 88 67 <0.001
Children (% with child) 43 27 0.027
Living in urban setting (%) 75 80 0.444
Living arrangements 0.034
Living alone (%) 5 13
With partner only (%) 31 30
With partner and children (%) 37 19
With children only (%) 3 2
Other adults (%) 24 38
Income 0.178
Below $59,999 (%) 26 24
$60,000- $79,999 (%) 21 17
$80,000 + (%) 46 48
Don’t know/no answer (%) 7 11Physical activity, anxiety and depression
The Chi-square goodness of fit analysis indicated that
more women without PCOS (64%) were physically active
than women with PCOS (48%) (p = 0.028). After covary-
ing/accounting for age and BMI, both physical activity
level (Wilk’s Lambda = 0.93) and PCOS status (Wilk’s
Lambda = 0.92) were significantly associated with the
mental health of the participants (combined dependent
variable of anxiety and depression). BMI had a significant
independent influence on mental health with higher BMI
associated with poorer mental health (Wilks’s Lambda =0
.94) yet no effect was observed for the covariate of age.
Women with PCOS (mean = 9.42 [SD = 3.76]) had higher
anxiety scores than women without PCOS (6.60 [3.63]).
This difference was significant (F(1,210) = 17.37, p < 0.001,
partial η2 = 0 .08). Women with PCOS (5.67 [3.76]) also
had higher depression scores than women without PCOS
(3.05 [3.15]), a difference which was also significant (F
(1,210) = 8.32, p = 0 .004, partial η2 = 0.04). Activity level
was not associated with anxiety (F(2,210) = 1.79, p = 0.18,
partial η2 = 0.01) but was significantly associated with de-
pression (F(2,210) = 13.62, p < 0.001, partial η2 = 0.06).
Physically active women (3.53 [2.88]) had significantly
lower depression scores than inactive women (6.41 [4.07]).
No significant effects were observed for the interaction of
PCOS status and activity level. The descriptive statistics
according to group and physical activity are presented in
Figure 1.
Exercise barriers
Table 2 details the exercise barriers identified by women
with and without PCOS. The number of exercise barriers
amongst women with and without PCOS was similar (t =
1.54, p = 0.216) with each group identifying approximately
four barriers. The barriers were assessed according to age
groups (18-30, 31- 40 and 41-50 years) and were deter-
mined to be similar in terms of the five most frequently
reported exercise barriers and so results are presented for
the whole sample. Lack of time and fatigue were the main
exercise barriers for both groups. Women with PCOS
were more likely to report a lack of confidence regarding
their ability to maintain exercise as a barrier (71% of
PCOS women, 50% of control women, p = 0.046). This
barrier was the third most commonly cited barrier for
both groups. Women with PCOS were also more likely to
report fear of injury and physical limitations as barriers to
exercise compared to the women in the control group.
Exercise motivators
The motivators identified by women with and without
PCOS are presented in Table 3. There were no differ-
ences between women in terms of PCOS status for the
number of motivators reported. Women with PCOS re-
ported no more motivators (x = 8.51, SD = 3.27) than
Table 2 Barriers to exercise for women with and
without PCOS
Barrier PCOS (%) Control (%) Χ2 (p)
Lack of time 121 (79) 46 (72) 0.33 (0.569)
Fatigue 118 (77) 44 (69) 0.44 (0.508)
Not confident can maintain* 109 (72) 32 (50) 3.97 (0.046)
Tiredness 57 (37) 16 (25) 2.32 (0.128)
Fear of injury* 47 (31) 11 (17) 4.08 (.043)
Physical limitations* 45 (29) 5 (8) 11.92 (0.001)
Bad weather 45 (29) 20 (31) 0.07 (0.796)
No motivation 40 (26) 24 (38) 2.25 (0.134)
Not important 39 (25) 13 (20) 0.56 (0.456)
Cost 26 (17) 10 (16) 0.03 (0.862)
Young children 17 (11) 4 (6) 1.47 (0.225)
Illness 13 (9) 3 (5) -
Spousal influence 4 (3) 1 (2) -
Other 3 (2) 0 (0) -
No enjoyment 0 (0) 0 (0) -
Note: *indicates significant difference between groups based on Chi-Square
goodness of fit analyses (p<0.05).
Figure 1 Mental health according to PCOS status and activity.
Panel A: Mean HADS Anxiety Score according to PCOS status and
activity. Panel B: Mean HADS Depression Score according to PCOS
status and activity. Error bars represent standard deviations, asignificant
difference in PCOS compared to control for active women (p<0.01);
bsignificant difference in PCOS compared to control for inactive
women (p<0.01); csignificant difference in active compared to inactive
for PCOS women (p<0.05); dsignificant difference in active compared to
inactive for control women (p= 0.05).
Table 3 Exercise motivators for women with and
without PCOS
Motivator PCOS (%) Control (%) Χ2 (p)
Control weight 144 (94) 52 (81) 0.97 (0.326)
Improve health 142 (93) 49 (77) 1.51 (0.220)
Increase energy 128 (84) 47 (73) 0.77 (0.380)
Stress reduction 123 (80) 47 (73) 0.32 (0.571)
Maintain health 121 (79) 45 (70) 0.54 (0.461)
Improve mood 117 (76) 43 (67) 0.57 (0.452)
Maintain fitness 115 (75) 51 (80) 0.16 (0.688)
Improve self confidence 103 (67) 34 (53) 1.63 (0.201)
Decrease risk of disease 100 (65) 37 (58) 0.40 (0.528)
Decrease risk of illness 71 (46) 31 (48) 0.04 (0.837)
Control medical condition* 61 (40) 12 (19) 7.48 (0.006)
Control blood glucose levels 59 (39) 16 (25) 3.06 (0.080)
Social interaction 54 (35) 16 (25) 1.67 (0.197)
Other 1 (1) 1 (2) -
Enjoyment 1 (1) 1 (2) -
Own space 0 (0) 1 (2) -
Note: *indicates significant difference between groups based on Chi-Square
goodness of fit analyses (p<0.05).
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0.607). Results are presented for the whole sample after
the top five motivators were assessed across age groups
and were determined to be similar. Weight control,
health improvements, increased energy, stress reduction
and health maintenance were the most commonly cited
motivators in both groups. Controlling a medical condi-
tion (PCOS = 40%, Control = 19%, p = 0.006) was more
commonly cited as an exercise motivator by women with
PCOS.
Physical activity supports
Table 4 summarises the exercise support providers identi-
fied by women with and without PCOS. Women with
PCOS (x = 3.80, SD = 1.96) were able to identify approxi-
mately 1 more support source than women without PCOS
(x = 3.20, SD = 1.69) (t = 4.19, p = 0.041). The 18-30 yearsold age group reported different support groups to the rest
of the sample and so results are presented for this group
separately (Table 4). In all groups the husband or partner
was the primary support provider, followed by friends and
parents. The 18-30 years old age group reported physical
activity instructors to be one of the top five support pro-
viders, whilst children were primary support providers for
Table 4 Support providers for women with and without PCOS: whole sample
Whole sample 18- 30 years old sample
Support PCOS (%) Control (%) Χ2 (p) PCOS (%) Control (%) Χ2 (pcp
Husband/partnera 116 (76) 37 (58) 2.42 (0.120) 52 (74) 14 (42) 8.83 (0.003)
Friends 93 (61) 30 (47) 1.82 (0.178) 46 (66) 22 (67) 0.01 (0.931)
Parents 86 (56) 24 (38) 3.45 (0.063) 49 (70) 21 (64) 0.27 (0.604)
Other family* 77 (50) 19 (30) 5.00 (0.025) 42 (60) 14 (42) 3.18 (0.075)
Children*a 65 (42) 16 (25) 4.31 (0.038) 15 (21) 2 (6) 8.33 (0.004)
Health care profs 42 (27) 14 (22) 0.51 (0.475) 22 (31) 8 (24) 0.89 (0.345)
Co-workers 40 (26) 13 (20) 0.78 (0.376) 24 (34) 9 (27) 0.80 (0.370)
Physical activity instructors 40 (26) 14 (22) 0.33 (0.564) 25 (36) 10 (30) 0.55 (0.460)
Myself 9 (6) 4 (6) 0.00 (1.00) 5 (7) 4 (12) 1.32 (0.251)
Other 4 (3) 0 (0) - 2 (3) 0 (0) -
Exercise friends/team 2 (1) 2 (3) - 2 (3) 0 (0) -
No one 1 (1) 1 (2) - 0 (0) 1 (3) -
Pets 1 (1) 1 (2) - 1 (1) 0 (0) -
Note: *indicates significant difference between groups in whole sample based on Chi-Square goodness of fit analyses (p<0.05).
aindicates significant difference between groups in 18-30 year old sample based on Chi-Square goodness of fit analyses (p<0.05).
Banting et al. BMC Women's Health 2014, 14:51 Page 6 of 9
http://www.biomedcentral.com/1472-6874/14/51the other age groups. For the whole sample, other family
were more frequently cited by women with PCOS as sup-
port providers (PCOS = 50%, Control = 30%, p = 0.025), as
were children (PCOS = 43%, Control = 25%, p = 0.038).
Discussion
In this novel formative research, fewer women with PCOS
reported being physically active compared to women with-
out PCOS. Additionally, women with PCOS had poorer
mental health, with higher depression and anxiety scores.
Relationships between activity and mental health showed
that being physically active was associated with lower de-
pression scores, after accounting for age, BMI and PCOS
status. There was no interaction effect of PCOS status and
physical activity; depression scores were lower in both
physically active groups similarly. Physical activity was not
significantly associated with lower anxiety after controlling
for age, BMI and PCOS status. Women with PCOS did
not identify additional barriers or motivators for physical
activity, although they did identify an additional supportive
influence than women without PCOS. The barriers, moti-
vators and support providers were similar between groups,
yet women with PCOS more often reported a lack of con-
fidence in their ability to maintain exercise, fear of injury
and physical limitations as barriers to physical activity.
These women were also more likely to report being moti-
vated to do physical activity in order to control a medical
condition.
As research and practice regarding physical activity
prescription as a management strategy for women with
PCOS has been significantly limited by poor engagement
and sustainability, formative research is important to as-
sess the association between mental health and activityresearch to explore the physical activity barriers, motiva-
tors and support providers for women with PCOS. The
current novel findings from a multiethnic community
based sample, show that physical activity was associated
with lower depression symptoms compared to physical
inactivity for all women after accounting for age, BMI
and PCOS. Unsurprisingly, both BMI and PCOS were sig-
nificantly associated with depression as has been found in
previous research [19,46]. The current results support
findings from a clinic-based study that being physically ac-
tive is associated with lower rates of depression in women
with PCOS [30]. Current results also strengthen claims
that participation in physical activity programs may be as-
sociated with lower depressive symptoms and improve-
ments in quality of life [31,47] and indicate the value of
exploring these associations further using interventional
and longitudinal research.
Physical activity was not significantly associated with
lower anxiety compared to being inactive after accounting
for age, BMI and PCOS. A higher BMI was associated
with greater anxiety which is consistent with previous re-
search [46]. Having PCOS was also associated with higher
anxiety, supporting the claim that PCOS is associated with
poor mental health outcomes [19]. These results are con-
sistent with findings in other populations [48]. Potentially
depression may be more associated with and a greater bar-
rier to physical activity than anxiety, with further research
needed.
In this sample, physic activity levels in women with
PCOS were lower compared to active women without
PCOS. Investigation into the barriers and motivators of
physical activity in this study emphasised that despite hav-
ing a medical condition and noting this as a motivator for
Banting et al. BMC Women's Health 2014, 14:51 Page 7 of 9
http://www.biomedcentral.com/1472-6874/14/51physical activity, women with PCOS still noted time and
fatigue as the key barriers to engaging in physical activity,
similar to the control group. Having a positive attitude to-
wards physical activity is insufficient for long-term phys-
ical activity engagement, as positive attitudes towards
physical activity do not correspond with actual increases
in physically active behaviour [49]. Additional factors such
as addressing barriers and enhancing support are likely to
be needed to increase engagement and sustainability in
physical activity in PCOS. In this context, women with
PCOS did note some specific barriers which should be
considered in physical activity prescription. These in-
cluded a lack of confidence in their ability to maintain
physical activity, fear of injury and physical limitations.
Given the role of physical activity in the management of
PCOS, a lack of confidence in maintaining physical activity
may indicate that women with PCOS need additional sup-
port and assistance in sustainable and effective physical
activity programs. Physical limitations and fear of injury
can be very inhibiting for an individual. Programs and ad-
vice may need to consider this barrier and develop strat-
egies to give women with PCOS more confidence in their
ability to perform physical activity safely and according to
their physical abilities.
Women with and without PCOS noted similar motiva-
tors for physical activity. Women with PCOS were more
likely to cite controlling a medical condition as a reason
for doing physical activity compared to the control group,
but only 40% of women with PCOS saw this as a motiv-
ator. No significant differences were observed for decreas-
ing risk of disease or illness or controlling blood glucose
levels as physical activity motivators between women with
or without PCOS. This is despite the fact that women with
PCOS have a higher mean BMI and greater risk of dia-
betes and cardio-metabolic risk factors [50]. This indicates
that the importance of physical activity for managing
current PCOS symptoms and minimising long-term com-
plications of PCOS may not be fully understood by women
with PCOS. As diet and physical activity are endorsed as
the primary management strategies for PCOS in recent evi-
dence based guidelines [26] better promotion of short and
long term benefits of lifestyle modification is warranted to
improve motivation for physical activity.
Women with PCOS indicated more support providers
for physical activity than the control group which is
positively associated with adherence to lifestyle modifi-
cations [49]. Whilst differences were observed across age
groups in terms of children being support providers, this
is likely to be due to the age of the women themselves
and their children in the 18-30 years old group. Support
from physical activity instructors and other health pro-
fessionals could be a way to engage more women with
physical activity for a longer time period [49]. This was
especially pertinent for women with PCOS aged 18-30 years, among whom one-third identified physical ac-
tivity instructors and health professionals as important
support providers or their physical activity pursuits.
Interestingly, when assessing the barriers, motivators and
support providers for physical activity for women with and
without PCOS with a healthy BMI, there were no differ-
ences between groups (data not shown). Whilst this does
indicate that some of the barriers, motivators and support
providers may be associated with the higher BMI, this dif-
ference may be relevant as women with PCOS are more
likely to be overweight, and physical activity prescription
should take this into consideration. However, despite
reporting similar barriers, motivators and support pro-
viders, only 48% of women with PCOS were active com-
pared to 69% of women without the condition (χ2 = 0.050).
Whilst standard scales and questionnaires can be used to
measure barriers, motivators and support providers, there
are clearly additional factors, unique to women with PCOS
that are not being detected. In future research, investiga-
tion of barriers and motivators specifically related to PCOS
would add value as it has been shown that hirsutism and
acne can result in a negative self-image [25,51] which is a
significant barrier to physical activity [52]. Women with
PCOS have also been found to sweat more than other
women during physical activity [53]. The physical symp-
toms, in addition to an increased prevalence of obesity in
this population have been found to be associated with an
increased level of self-consciousness during physical activ-
ity [51]. The development of a tailored psychometrically
validated questionnaire to examine the specific barriers
and motivators of physical activity for women with PCOS
is needed. Considering the geographic location, cultural
environment and other unique population factors may also
be important when administering questionnaires of this
nature.
Limitations of this research include that it relies on self-
report, is cross-sectional in design, has uneven group
numbers and has a limited measures of physical activity.
Although both groups were recruited from the general
community, more women with PCOS volunteered than
women without PCOS and there were some demographic
differences between groups with potential of volunteer
bias leading to an under or over–estimation of effect. Also
barriers and motivators to physical activity are assessed as
frequencies rather than ranking and use a non-validated
questionnaire with no available validated questionnaires in
PCOS. Splitting the women into three age groups when
assessing barriers, motivators and support providers does
inherently reduce the variance associated with the meas-
ure. However, given the exploratory and hypothesis gener-
ating nature of the study, assessing barriers, motivators
and support providers according to age assists in the plan-
ning of future research addressing the factors which help
and/or hinder women with PCOS’ physical activity plans.
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community-based sample, incorporating both anxiety
and depression, and including a control group, which
provides formative data on physical activity as a compo-
nent of first line management in PCOS.
Conclusions
This study found that less women with PCOS were phys-
ically active compared to women without PCOS and that
physical activity was associated with milder depression.
While physical activity barriers, motivators and supports
for women with PCOS are similar to those without PCOS,
additional barriers in PCOS may limit engagement and
sustainability of physical activity over the long term. This
formative research will assist understanding of the inter-
action between mental health and active lifestyles for
women with PCOS. Barriers, motivators and the need for
support should be considered when prescribing and pro-
moting of physical activity as a management strategy for
PCOS. Future research may focus on eliciting specific
physical activity barriers, motivators and support providers
from women with PCOS in order to understand how to
better prescribe physical activity as a management strategy
to this population. Including theoretical frameworks in
order to structure research may be advantageous, the de-
velopment and use of validated questionnaires and of ob-
jective measures of physical activity may also strengthen
findings in future research. Ultimately, current results sup-
port the need for more investigation regarding the physical
and psychological impact of physical activity in PCOS to
identify evidence-based strategies to optimise motivation
for and engagement in sustainable physical activity.
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